IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q1 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $96,000 | 0.0% | 5,748 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $96,000 | -15.8% | 5,748 | +2.7% | 0.00% | -20.0% |
| Q3 2017 | $114,000 | +25.3% | 5,598 | -1.1% | 0.01% | +25.0% |
| Q2 2017 | $91,000 | +2933.3% | 5,658 | +2660.0% | 0.00% | – |
| Q4 2016 | $3,000 | -57.1% | 205 | -34.9% | 0.00% | – |
| Q3 2016 | $7,000 | +16.7% | 315 | +48.6% | 0.00% | – |
| Q2 2016 | $6,000 | – | 212 | +2928.6% | 0.00% | – |
| Q4 2015 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |